Aprilia has marked 10 years since its RS-GP first lined up on the MotoGP grid in spectacular fashion. Rather than producing a ...

GP, a limited-edition track-only superbike from Noale’s Racing Department, has sold out within just 14 days of its debut. All ...

A tastefully customized RSV4 isn’t something you’ll see on a daily basis, so take your time admiring this incredible specimen ...

Presented at the Catalunya Grand Prix, the RSV4 X-GP is the special edition created directly from Aprilia Racing’s cutting-edge know-how in MotoGP and produced in a limited-edition quantity of 30 ...

A new Cochrane review demonstrates that vaccines for respiratory syncytial virus (RSV) are both safe and effective in protecting vulnerable groups that are most at risk of serious illness, including ...

Aprilia, the Italian motorcycle manufacturer, has launched the limited-edition SR-GP Replica 175 hp-e in India. The MotoGP-inspired version of the SR 175 hp-e is available at a starting price of Rs ...

This article is part of “Innovations In: RSV,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. Scientists have made monumental ...

RSV vaccines were 58% effective at preventing RSV-associated hospitalizations among adults age 60 or older across two seasons. Vaccine effectiveness against all-cause cardiorespiratory ...

Clesrovimab is a long-acting investigational monoclonal antibody against site IV of the respiratory syncytial virus (RSV) fusion protein. Data regarding the safety and efficacy of clesrovimab in ...

The INCompetition Aprilia Racing team will make a welcome return this weekend. The team will join the British Superbike Championship round at Donington Park with a new rider. Brad Perie will race in ...

For infants less than 8 months of age born during or entering their first RSV season and not otherwise protected through maternal vaccination, nirsevimab is considered the first-line recommended ...

A new UK study shows that vaccinating pregnant women against RSV has led to a staggering 72% drop in hospitalizations of newborns with severe lung infections. By passing virus-fighting antibodies to ...